The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
AMR-Lung – AntiMicrobial Resistance in Lung infections
CRC Chairs: Stuart Elborn (Queen's University Belfast, Belfast, United Kingdom) Miquel Ekkelenkamp (UMC Utrecht, Utrecht, The Netherlands) Stephanie Thee (Charité Universitaetsmedizin Berlin, Berlin, Germany)
/* Main content & Sidebar */ ?>
About AMR-Lung
The AMR-Lung (AntiMicrobial Resistance in Lung infections) clinical research collaboration was launched by the European Respiratory Society (ERS) in 2022. The World Health Organisation (WHO) has declared antimicrobial resistance as one of the top 10 public health threats the world is currently facing. Moreover, the COVID-19 pandemic has exposed the vulnerability to infectious diseases, which may be caused either by new (respiratory) pathogens of zoonotic origin, or by multi-resistant / difficult-to-treat variants of already known human pathogens. This has spotlighted the urgent need to use current antibiotics judiciously and to develop new anti-microbial strategies, particularly against resistant pathogens. The use of antibiotics has proven lifesaving for many different infections. However, the overuse of them – often misused for non-bacterial or non-infectious diseases has led to development of antimicrobial resistance and thus to a sharp decline in their effectiveness. New partnership models are required which share risk, resources and expertise across academia, philanthropies, industry and the public sector. This CRC will focus on patient groups where complex infections cause lung disease and where there is a need to both develop new effective antibiotics and to use current drugs available in a better way.
Specific aims
The vision of the CRC AMR-Lung is to develop a better understanding of the extent of the antimicrobial resistance-associated problems in pulmonology, to develop appropriate diagnostic tools to predict effect of treatment, and to improve patient treatment, in particular with regards to antibiotic prescribing.
With this purpose, AMR-Lung aims specifically to:
Analyse the epidemiology of respiratory pathogens, with an emphasis on chronic lung infection.
Establish which methodologies are currently employed in microbiological diagnostics of infection from airway samples, and critically review their clinical value.
Perform basic studies, exploring the utility of novel diagnostic tests to predict response to antibiotic treatment in chronic lung infection.
Unite stakeholders in the area of complex pulmonary infection (respiratory medicine, infectious diseases/microbiology and public health, pharmaceutical companies and patient representatives) and develop a research agenda for the coming years.
Define the principles of prudent and targeted antibiotic use in complex lung infections.
Stakeholders
The CRC AMR-Lung Executive Scientific committee is composed of the CRC chairs, clinician researchers, experts in translational research, early career members and patient representatives.
Contact
If you are interested in more information about CRC AMR-Lung or would like to join the network, please contact scientific@ersnet.org.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.